NUZ vs VBS

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

NUZ

NEURITHERA FPO [NUZ]

41LOW

VBS

VECTUS BIO FPO [VBS]

41LOW

Score Breakdown

NUZ VBS
Technical
48
70
Catalyst
53
55
Sentiment
50
50
Fundamental
43
12
Momentum
36
71
Risk Gate
50
47

Key Metrics

NUZ Metric VBS
$51.2MMarket Cap$11.1M
1.1MAvg Volume (20d)47K
N/AShort InterestN/A
$0.18552-Week High$0.455
$0.05552-Week Low$0.037
-3.0%Daily Change+11.4%
$0.065Entry Price$0.195
-147.1%ROEN/A
-248.4%Profit MarginN/A

Active Signals

NUZ Signals

●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.8 quarters)
●Moderate P/S ratio (8.6x)
●Strong revenue growth (+290%)
●Near 52-week low (9% of range)
●Small-cap ($20-100M)
●Capital raise activity (1 events)
●Deeply negative margins (-248%)

VBS Signals

●RSI is running hot — overbought territory, so expect some pullback risk
●MACD momentum is picking up steam
●Stochastic is stretched into overbought — could need a breather
●Pressing against the upper Bollinger Band — extended and may need to cool off
●Trading above both moving averages — the trend is your friend here
●Above-average volume (1.5x) on a green day — buyers stepping up
●Just broke above 20-day resistance — a level that was capping price, now cleared
●On a tear — up 39.3% over the last 5 days

Ask Scout AI to compare NUZ and VBS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
NUZ Full Analysis → VBS Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).